[go: up one dir, main page]

Rozman et al., 1981 - Google Patents

Enhanced fecal elimination of stored hexachlorobenzene from rats and rhesus monkeys by hexadecane or mineral oil

Rozman et al., 1981

Document ID
5908326207765835880
Author
Rozman K
Rozman T
Greim H
Publication year
Publication venue
Toxicology

External Links

Snippet

The effect of various dietary treatments on the fecal excretion of [14 C]-hexachlorobenzene (HCB) was studied in rats and rhesus monkeys. Cholestyramine and sesame oil failed to influence fecal excretion of HCB and/or metabolites. However, dietary administration of n …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Rozman et al. Enhanced fecal elimination of stored hexachlorobenzene from rats and rhesus monkeys by hexadecane or mineral oil
Boylan et al. Cholestyramine: use as a new therapeutic approach for chlordecone (kepone) poisoning
Valberg et al. Gastrointestinal metabolism of cadmium in experimental iron deficiency
Rowland et al. The effect of various dietary fibres on tissue concentration and chemical form of mercury after methylmercury exposure in mice
Fang Interaction of selenium and mercury in the rat
Argenzio et al. Intestinal oxalate-degrading bacteria reduce oxalate absorption and toxicity in guinea pigs
Modigliani et al. Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria
Eyong et al. Haematoxic effects following ingestion of Nigerian crude oil and crude oil polluted shellfish by rats
Charbonneau et al. Arsenic excretion by monkeys dosed with arsenic-containing fish or with inorganic arsenic
Andersen et al. Effects of simultaneous low-level dietary supplementation with inorganic and organic selenium on whole-body, blood, and organ levels of toxic metals in mice.
Doyle et al. The effects of a low level of dietary cadmium on blood pressure, 24Na, 42K, and water retention in growing rats
US4122169A (en) Activated carbon-sorbital composition and adsorption-expulsion treatment therewith
Langlands et al. Selenium excretion in sheep
Yeoh et al. Absorption of mercuric sulphide following oral administration in mice
Planas-Bohne The influence of chelating agents on the distribution and biotransformation of methylmercuric chloride in rats.
Morris et al. The distribution of radioactivity following the feeding of carbon 14-labeled 2-acetylaminofluorene to rats
Malluche et al. Aluminum-related bone disease
KIYOZUMI et al. Studies on poisonous metals. IX. Effects of dietary fibers on absorption of cadmium in rats
Ohsawa et al. Modified distribution of lymphocyte subpopulation in blood and spleen from mice exposed to cadmium
Kobayashi et al. Accumulation of cadmium in organs of mice fed on cadmium-polluted rice
AU758830B2 (en) Chelate compound-containing antibacterial agent for helicobacter pylori
Jacobs et al. Decreased long-term retention of 115mCd in Japanese quail produced by a combined supplement of zinc, copper, and manganese
Rozman et al. Effect of mineral oil and/or cholestyramine in the diet on biliary and intestinal elimination of 2, 4, 5, 2′, 4′, 5′‐hexabromobiphenyl in the rhesus monkey
Imondi et al. Gastrointestinal sorbents for the treatment of uremia. I. Lightly cross-linked carboxyvinyl polymers
Rozman et al. Effect of cholestyramine on the disposition of pentachlorophenol in rhesus monkeys